| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
134,770,000 |
| Market
Cap: |
19.22(B) |
| Last
Volume: |
618,418 |
Avg
Vol: |
1,171,182 |
| 52
Week Range: |
$120.62 - $144.92 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 724 |
| Guru Rank Value : 1.3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
1,760 |
18,097 |
18,097 |
100,860 |
| Total Sell Value |
$246,400 |
$2,309,019 |
$2,309,019 |
$14,306,288 |
| Total People Sold |
1 |
4 |
4 |
6 |
| Total Sell Transactions |
1 |
7 |
7 |
21 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
• – – |
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,348 |
71,289 |
|
- |
|
| Davis J. E. |
EVP, General Diagnostics |
• – – |
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,964 |
42,581 |
|
- |
|
| Morrison Denise M |
Director |
– • – |
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
484 |
484 |
|
- |
|
| Eglinton Manner Carrie |
SVP, Advanced Diagnostics |
• – – |
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,041 |
23,548 |
|
- |
|
| Klug Robert A |
VP, Corporate Controller |
• – – |
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
347 |
5,537 |
|
- |
|
| Guinan Mark |
Executive Vice President & CFO |
• – – |
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
5,195 |
63,395 |
|
- |
|
| Eglinton Manner Carrie |
SVP, Advanced Diagnostics |
• – – |
2018-12-31 |
4 |
D |
$82.27 |
$145,371 |
D/D |
(1,767) |
19,507 |
|
- |
|
| Klug Robert A |
VP, Corporate Controller |
• – – |
2018-10-12 |
4 |
D |
$100.51 |
$804 |
D/D |
(8) |
4,972 |
|
- |
|
| Klug Robert A |
VP, Corporate Controller |
• – – |
2018-08-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(21) |
4,928 |
|
- |
|
| Cunningham Everett |
SVP, Commercial |
• – – |
2018-07-10 |
4 |
AS |
$112.00 |
$4,516,736 |
D/D |
(40,328) |
38,261 |
|
- |
|
| Cunningham Everett |
SVP, Commercial |
• – – |
2018-07-10 |
4 |
OE |
$71.17 |
$2,870,144 |
D/D |
40,328 |
78,589 |
|
- |
|
| Prevoznik Michael E |
SVP & General Counsel |
• – – |
2018-07-10 |
4 |
AS |
$113.07 |
$3,480,141 |
D/D |
(30,780) |
39,791 |
|
- |
|
| Prevoznik Michael E |
SVP & General Counsel |
• – – |
2018-07-10 |
4 |
OE |
$57.61 |
$1,773,082 |
D/D |
30,780 |
70,551 |
|
- |
|
| Cunningham Everett |
SVP, Commercial |
• – – |
2018-07-02 |
4 |
AS |
$109.60 |
$7,465,043 |
D/D |
(68,069) |
38,261 |
|
- |
|
| Cunningham Everett |
SVP, Commercial |
• – – |
2018-07-02 |
4 |
OE |
$52.17 |
$3,699,903 |
D/D |
60,222 |
84,844 |
|
- |
|
| Britell Jenne K |
Director |
– • – |
2018-06-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
8,704 |
14,479 |
|
- |
|
| Leiden Jeffrey M |
Director |
– • – |
2018-05-29 |
4 |
S |
$105.61 |
$173,623 |
D/D |
(1,644) |
6,000 |
|
- |
|
| Guinan Mark |
Executive Vice President & CFO |
• – – |
2018-05-25 |
4 |
AS |
$105.42 |
$6,504,682 |
D/D |
(61,533) |
58,200 |
|
- |
|
| Guinan Mark |
Executive Vice President & CFO |
• – – |
2018-05-25 |
4 |
OE |
$58.37 |
$3,591,374 |
D/D |
61,533 |
119,733 |
|
- |
|
| Rusckowski Stephen H |
Chairman, President and CEO |
• • – |
2018-05-25 |
4 |
AS |
$107.00 |
$18,028,430 |
D/D |
(168,490) |
191,069 |
|
- |
|
| Rusckowski Stephen H |
Chairman, President and CEO |
• • – |
2018-05-25 |
4 |
OE |
$56.12 |
$9,455,659 |
D/D |
168,490 |
359,559 |
|
- |
|
| Leiden Jeffrey M |
Director |
– • – |
2018-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,644 |
7,644 |
|
- |
|
| Britell Jenne K |
Director |
– • – |
2018-05-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,644 |
23,183 |
|
- |
|
| Ring Timothy M |
Director |
– • – |
2018-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,644 |
16,496 |
|
- |
|
| Pfeiffer Gary M |
Director |
– • – |
2018-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,644 |
17,462 |
|
- |
|
787 Records found
|
|
Page 18 of 32 |
|
|
0.05 (0.04%) 
